Optical Newswire
1 - UnitedHealthcare’s Golden Rule Introduces Cost-Effective Dental and Vision Coverage Options for Consumers in Six States
INDIANAPOLIS-(Business Wire)-September 29, 2009 - UnitedHealthcare’s Golden Rule Insurance Company has introduced new cost-effective dental and vision care coverage options for individuals and families in Alaska, Arizona, Colorado, Iowa, South Dakota and Wyoming. The new dental plans are available...
2 - Computable Genomix Announces Contest For Genomics Researchers
MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...
3 - pSivida Reports Safety and Efficacy Results from 18-Month Interim Readout of Human PK Iluvien® Study
WATERTOWN, Mass.-(Business Wire)-September 29, 2009 - pSivida Corp (NASDAQ: PSDV)(ASX: PVA), a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today...
4 - Research and Markets: The Ophthalmic Pharmaceutical Market Outlook to 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts - Now Available
DUBLIN-(Business Wire)-September 25, 2009 - Research and Markets , dry eye syndrome, ophthalmic infections and inflammation, etc.? What are the most promising ophthalmic products in clinical development and their forecast commercial potential through 2014? Which companies are best positioned to...
5 - pSivida Corp. Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2009
WATERTOWN, Mass.-(Business Wire)-September 24, 2009 - pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) (FF: PV3), a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back of the eye diseases, today announced financial...
6 - GE Centricity EMR Helps Power Community Health Network’s Latest Innovation
BARRINGTON, Ill.-(Business Wire)-September 24, 2009 - GE Healthcare, a leading provider of healthcare information technology, is providing digital medical record technology for the Jane Pauley Community Health Center (Indianapolis). The center, which opened Wednesday, is a unique collaboration...
7 - pSivida Anounces New Iluvien® Pilot Study in Patients with Macular Edema Secondary to Retinal Vein Occlusion
WATERTOWN, Mass.-(Business Wire)-September 23, 2009 - pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FWB:PV3), a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease...
8 - Lux Biosciences Reports Phase 1 Safety Results and Open Label Efficacy Results for LX214, a Potential Best-in-Class Treatment for Dry Eye
JERSEY CITY, N.J.-(Business Wire)-September 23, 2009 - Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, today announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company’s potential best-in-class...
9 - Dr. Brian S. Boxer Wachler Introduces I-Brite™ Eye Whitening
BEVERLY HILLS, Calif.-(Business Wire)-September 22, 2009 - World renowned ophthalmologist and vision specialist Dr. Brian S. Boxer Wachler (“Dr. Brian”) introduces I-Brite™ eye whitening, an original and breakthrough procedure created to treat a very common problem: chronic red eyes. It is...
10 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis
BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...
11 - Reportlinker Adds The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts
NEW YORK-(Business Wire)-September 21, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts...
12 - CIGNA Volunteer of the Year in Phoenix Gives Sight to the Needy
PHILADELPHIA-(Business Wire)-September 18, 2009 - The CIGNA (NYSE:CI) Foundation today named Dr. Eva Liang, an ophthalmologist with the Cigna Medical Group in Phoenix, as the company’s Volunteer of the Year. Dr. Liang founded the Sight for Life Foundation in 2001 while in private practice in Las...
13 - pSivida CEO to Discuss New Technologies in Retinal Drug Delivery at 5th Annual Ophthalmic Drug Development and Delivery Summit
BOSTON-(Business Wire)-September 18, 2009 - pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced that Dr. Paul Ashton, CEO, will lead a discussion on New Technologies in Retinal Drug Delivery at the 5th Annual Ophthalmic Drug Development and Delivery...
14 - pSivida Corp Announces Q4 and Fiscal Year 2009 Financial Results Release Date and Conference Call Information
WATERTOWN, Mass.-(Business Wire)-September 17, 2009 - pSivida Corp. (NASDAQ:PSDV), (ASX:PVA), (FF:PV3), a leading drug delivery company, today announced that its financial results for the fourth quarter and fiscal year ended June 30, 2009, will be released after market close on Thursday, September...
15 - Hythiam Raises Approximately $7 Million in Registered Direct Offering
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...
16 - Research and Markets: The Comprehensive Ophthalmology Review Course is an Intensive Program Aimed at Residents, Fellows, and Practicing Ophthalmologists
DUBLIN-(Business Wire)-September 17, 2009 - Research and Markets , as well as payment of a processing fee. A note on the available formats: DVD: Includes 13 DVDs with carrying case, a comprehensive course syllabus on CD-ROM and activity posttest. CD: Includes 21 audio CDs, carrying case...
17 - EBD Group and Defined Health Form an Alliance on Conference Content
CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.-(Business Wire)-September 16, 2009 - EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under...
18 - Blind Patient Regains Sight with “Eyetooth” Implanted in Her Eye
MIAMI-(Business Wire)-September 16, 2009 - Blind for nine years, Sharron “Kay” Thornton has just regained her sight through a first-in-the-U.S. surgical procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. The procedure — modified...
19 - Los Angeles Cosmetic Surgeon Discusses Non-Surgical Facial Rejuvenation in Harper’s Bazaar Magazine
LOS ANGELES-(Business Wire)-September 16, 2009 - Dr. Kenneth D. Steinsapir, M.D., a Los Angeles cosmetic surgeon, is featured this September in Harper’s Bazaar, the iconic magazine which epitomizes all that is sophisticated in fashion and beauty, discussing a non-surgical alternative for those...
20 - Pilkington Acquires License from Research Frontiers to Produce and Offer Environmentally Friendly SPD-Smart Automotive Glass Products
FRANKFURT-(Business Wire)-September 15, 2009 - Today at the Frankfurt International Motor Show, Pilkington Group Limited announced that it has acquired a new license from Research Frontiers Inc. (Nasdaq: REFR) to offer SPD-Smart automotive end-products globally. Research Frontiers is the developer...
21 - OptiMedica Names Alan Marquardt as New Vice President, Regulatory, Clinical and Quality
SANTA CLARA, Calif.-(Business Wire)-September 15, 2009 - Global ophthalmic company OptiMedica Corp. has appointed Alan Marquardt to the newly created position of vice president, regulatory, clinical and quality. Marquardt joins OptiMedica with more than two decades of equivalent senior management...
22 - AzaSite® Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage
ALAMEDA, Calif.-(Business Wire)-September 14, 2009 - InSite Vision Incorporated (OTCBB: INSV) today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite® (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in...
23 - Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG
HUENENBERG, Switzerland & ZURICH-(Business Wire)-September 13, 2009 - Alcon (NYSE:ACL) announced today that it has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. Alcon will pay ESBATech shareholders $150 million in cash at closing, plus contingent...
24 - Research and Markets: 2009 Worldwide Optical Goods Stores Industry Report
DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets selling non-prescription eyeglasses. Related Industries Pharmacies & Drug Stores Department Stores Offices of Optometrists U.S. Census Categories NAICS 44613 - Optical Goods Stores is comparable to: SIC 5995 - Optical goods stores...
25 - Fitch Ratings Affirms McKesson's IDR at 'BBB+'; Outlook Stable
CHICAGO-(Business Wire)-September 10, 2009 - Fitch Ratings has affirmed the Issuer Default Rating (IDR) and debt ratings for McKesson Corp. (MCK) as follows. —IDR at 'BBB+'; —Senior unsecured credit facility at 'BBB+'; —Senior unsecured debt at 'BBB+'; —Short-term IDR at...
26 - Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015
NEW YORK-(Business Wire)-September 10, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015...
27 - Signature Eyewear Reports 15th Consecutive Profitable Quarter
LOS ANGELES-(Business Wire)-September 10, 2009 - Signature Eyewear, Inc. (OTCBB:SEYE) reported net income of $155,000 on net sales of $5.9 million for the quarter ended July 31, 2009 and net income of $570,000 on net sales of $18 million for the nine months ended July 31, 2009. This compares to...
28 - Presbia Introduces Breakthrough Micro-Lens Treatment for Presbyopia
AMSTERDAM-(Business Wire)-September 10, 2009 - Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery...
29 - Research and Markets: Eye Infections Therapy Area Pipeline Report Provides Insight Into the Pipeline Status of Eye Infections Drugs by Company and by Stage
DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets has announced the addition of the "Eye Infections Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Eye Infections Therapy Area Pipeline Report contains detailed information on the eye infections drug...
30 - Acucela Appoints Glen Y. Sato to Board of Directors
BOTHELL, Wash.-(Business Wire)-September 9, 2009 - Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today the appointment of Glen Y. Sato, a partner in the Life Sciences and Corporate practice groups of the law firm Cooley...
31 - pSivida to Webcast Presentation at Rodman & Renshaw Health Care Conference
BOSTON-(Business Wire)-September 9, 2009 - pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced it will webcast a live presentation at the Rodman & Renshaw Annual Health Care Conference in New York, September 10. Dr. Paul Ashton, president and chief...
32 - Amerinet Named Provider of Choice by National Rural Health Association Partnership
ST. LOUIS-(Business Wire)-September 8, 2009 - In recognition of their commitment to helping rural healthcare providers reduce costs and improve quality, Amerinet, a leading national healthcare group purchasing organization, has been named a “Provider of Choice” by the National Rural Health...
33 - Lux Biosciences to Present at the Thomas Weisel Partners Health Care Conference
JERSEY CITY, N.J.-(Business Wire)-September 8, 2009 - Lux Biosciences, a privately held biotechnology company focused on the treatment of ophthalmic diseases, announced today that Ulrich Grau, Ph.D., the company’s president and chief executive officer, will present at the Thomas Weisel Partner’s...
34 - Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009
AMITYVILLE, N.Y.-(Business Wire)-September 4, 2009 - Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its first quarter of Fiscal Year 2010 ended July 31, 2009, prior to the market opening on Wednesday September 9, 2009 and will hold a conference call to...
35 - Christopher Payan to Depart Emerging Vision
GARDEN CITY, N.Y.-(Business Wire)-September 3, 2009 - Emerging Vision, Inc. (OTCBB – ISEE) today announced that Christopher Payan, the Company’s Chief Executive Officer and President, and the Company have determined not to renew Mr. Payan’s employment agreement which is set to expire on...
36 - Vivakor Announces Award of Grant from the National Institutes of Health-National Eye Institute
IRVINE, Calif.-(Business Wire)-September 3, 2009 - Vivakor, Inc. (OTCBB: VIVK) announced that the National Institutes of Health-National Eye Institute has awarded a grant to Vivakor, Inc. in Coralville, IA through the Small Business Innovation Research Awards. Vivakor will use the grant, which was...
37 - Merck Launches SAFLUTAN® (tafluprost) in International Markets
WHITEHOUSE STATION, N.J.-(Business Wire)-September 3, 2009 - Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today...
38 - Dioptics Launches Haven Fits Over Sunwear™
SMITHFIELD, R.I.-(Business Wire)-September 2, 2009 - Dioptics Medical Products, Inc., a subsidiary of FGX International Inc., is launching Haven Fits Over Sunwear™ at the 2009 Vision Expo West show in Las Vegas, NV. This special collection features premium polarized sunglasses and ClipOns designed...
39 - Acucela to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
BOTHELL, Wash.-(Business Wire)-September 2, 2009 - Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will present a company...
40 - MedAssets to Present at Two Investor Conferences in September
ATLANTA-(Business Wire)-August 27, 2009 - MedAssets, Inc. (NASDAQ: MDAS) today announced that its management team will participate in investment firm conferences in September 2009. The Company is scheduled to present at Baird's 2009 Health Care Conference on Thursday, September 10 at 9:00 am ET in...
41 - CIGNA Team Ready to Roll in the Fight against Cancer
PHILADELPHIA-(Business Wire)-August 21, 2009 - Nearly 100 members of the CIGNA (NYSE: CI) Health Awareness Tour team will walk, bike and run into Blue Bell Sunday to help raise money and awareness for cancer prevention. CIGNA’s team will take part in the Lance Armstrong Foundation’s Livestrong...
42 - Lundbeck Inc. Announces FDA Marketing Approval for Sabril for the Treatment of Two Difficult-to-Treat Epilepsies
DEERFIELD, Ill.-(Business Wire)-August 21, 2009 - Lundbeck Inc. (“Lundbeck”), a wholly owned subsidiary of H. Lundbeck A/S in Denmark (Copenhagen: LUN), announced today that the U.S. Food and Drug Administration (FDA) has granted two New Drug Application (NDA) approvals for Sabril® (vigabatrin...
43 - Novaled Announces a Large Area OLED Device Fulfilling International Lighting Specifications
DRESDEN, Germany-(Business Wire)-August 20, 2009 - Novaled developed a 15x15 cm white OLED device with a thickness of less than 2 mm. Die Struktur der OLED stack allows for a natural and warm white light performing a very high color rendering index (CRI) of 90. The perception of this light is...
44 - Ophthalmic Imaging Systems Announces Second Quarter 2009 Results
SACRAMENTO, Calif.-(Business Wire)-August 14, 2009 - Ophthalmic Imaging Systems (OIS) (OTCBB:OISI), a leading digital imaging, image management and EMR company today reported its financial results for the three and six month periods ended June 30, 2009 and provided an update on recent corporate...
45 - Health Net Federal Services Proudly Sponsors Operation Peer Support at the Blinded Veterans Association 64th National Convention
RANCHO CORDOVA, Calif.-(Business Wire)-August 14, 2009 - Health Net Federal Services, LLC, the government operations division of Health Net, Inc. (NYSE:HNT), today announced its sponsorship of Operation Peer Support at the Blinded Veterans Association (BVA) 64th National Convention in Portland...
46 - Always Best Care Senior Services Recognizes Cataract Awareness Month
ROSEVILLE, Calif.-(Business Wire)-August 13, 2009 - Developing mostly among individuals over the age of 55, eye cataracts are cloudy or opaque areas in the lens of the eye that can interfere with vision. There is no way to prevent cataracts and currently the only way to treat them is to surgically...
47 - Thousands of People Seeking Care at Remote Area Medical Event
LOS ANGELES-(Business Wire)-August 13, 2009 - Remote Area Medical (RAM), the global non-profit that has turned the L.A. Forum into the nation’s largest healthcare event, has experienced high levels of demand for services during the first two days, August 11 and August 12. Each day, volunteer...
48 - Maryland Governor Martin O’Malley and JDRF Lead Distinguished Group of 2009 “Stem Cell Action” Honorees
WASHINGTON-(Business Wire)-August 13, 2009 - The Genetics Policy Institute (GPI) will honor Maryland Governor Martin O’Malley, the Juvenile Diabetes Research Foundation (JDRF), two leading Michigan stem cell organizations and two patient-advocates who serve on the Maryland Stem Cell Commission...
49 - Research and Markets: U.S. Market for Diagnostic Opthalmic Devices 2009 Report Reveals Total U.S. Diagnostic Ophthalmic Equipment Market was Valued at $320.8 Million in 2008
DUBLIN-(Business Wire)-August 12, 2009 - Research and Markets has announced the addition of the "U.S. Market for Diagnostic Opthalmic Devices 2009" report to their offering. The total U.S. diagnostic ophthalmic equipment market was valued at $320.8 million in 2008. The market for diagnostic...
50 - Akorn Reports Second Quarter 2009 Financial Results
LAKE FOREST, Ill.-(Business Wire)-August 11, 2009 - Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009. Total revenue for the second quarter 2009 was $16.3 million, versus $21.2 million in the second quarter 2008...
51 - Gene Signal Announces Publication of Phase I Data Highlighting Safety of GS-101 for Diseases of the Eye
LAUSANNE, Switzerland-(Business Wire)-August 11, 2009 - Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced publication of data from a phase I study demonstrating that the antisense oligonucleotide GS-101 (eye drops) is safe, with no...
52 - Research and Markets: Soft Contact Lenses Clinical Trial Analysis - An Essential Source Of Data And Information Pertaining To Product Clinical Trials Being Carried
DUBLIN-(Business Wire)-August 7, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Soft Contact Lenses Clinical Trial Analysis" to their offering. Global Markets Direct's "Soft Contact Lenses Clinical Trials Analysis" is an essential source of data and...
53 - InSite Vision Reports Second Quarter 2009 Financial Results
ALAMEDA, Calif.-(Business Wire)-August 6, 2009 - InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended June 30, 2009. Total revenue for the second quarter of 2009 was $1.9 million with a net loss of $3.7 million. “This quarter, we achieved a number of...
54 - Michael Chisholm Joins Scan-Optics as Solution Design Consultant
MANCHESTER, Conn.-(Business Wire)-August 6, 2009 - Michael Chisholm has joined Scan-Optics as a Solution Design Consultant. He will work closely with sales and applications engineering teams, and with customers, to design and implement the custom solutions that have been Scan-Optics’ hallmark...
55 - GE Global Research Biosciences Technology Organization Marks 5th Anniversary, Celebrates Technical Achievements
NISKAYUNA, N.Y.-(Business Wire)-August 6, 2009 - From creating a new business in digital pathology to developing next generation diagnostic imaging agents and life sciences tools that are breaking new ground in the detection and treatment of disease, the Biosciences technology organization at GE...
56 - FGX International Reports Increase in Second Quarter Revenue and Earnings from Continuing Operations; Reaffirms 2009 Guidance
SMITHFIELD, R.I.-(Business Wire)-August 5, 2009 - FGX International (NASDAQ: FGXI), a leading designer and marketer of non-prescription reading glasses and sunglasses, today announced financial results for its second fiscal quarter ended July 4, 2009. Highlights for the quarter include: Net sales...
57 - Welch Allyn Connectivity Website Assists Physicians with Transition to the Digital Age
SKANEATELES FALLS, N.Y.-(Business Wire)-August 5, 2009 - Welch Allyn, a leading global manufacturer of frontline products and solutions, today introduced an online tool designed to educate doctors on the benefits of connectivity. The new website (www.welchallyn.com/wafor/connectivity/cp-default.htm...
58 - Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
NEWARK, Calif.-(Business Wire)-August 4, 2009 - Oraya Therapeutics, Inc., a medical technology company developing radiosurgical treatments for eye diseases, today announced the appointment of Jim Taylor as President and Chief Executive Officer. Mr. Taylor brings over 25 years of experience in the...
59 - California Rx Card Has Saved Residents over $26.2 Million
SACRAMENTO, Calif.-(Business Wire)-August 3, 2009 - California residents have saved over $26.2 million on prescription drugs through California Rx Card since the launch of the free statewide prescription assistance program. The program, which offers free discount drug cards to California...
60 - FGX International Inc. Launches New Collection of Eco-Friendly Reading Glasses
SMITHFIELD, R.I.-(Business Wire)-August 3, 2009 - FGX International Inc, a leading designer and manufacturer of non-prescription reading glasses, announced the launch of its Green View collection today, a line of eco-friendly, over-the-counter reading glasses now available in stores. This special...
61 - Allergan Reports Second Quarter 2009 Operating Results
IRVINE, Calif.-(Business Wire)-July 31, 2009 - Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2009. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2009 to stockholders...
62 - InSite Vision to Report Financial Results for the Second Quarter on August 6, 2009
ALAMEDA, Calif.-(Business Wire)-July 30, 2009 - InSite Vision Incorporated (OTCBB:INSV) announced today that it will release financial results for the second quarter 2009 on Thursday, August 6, 2009. Company management will host a conference call beginning at 4:30 PM EDT/1:30 PM PDT to discuss...
63 - Research and Markets: Optical Industry - Business Ratio Report Analyses Company and Industry Performance over The Three Years Up To 7th August 2008 For The UK
DUBLIN-(Business Wire)-July 30, 2009 - Research and Markets Ltd For more information visit http://www.researchandmarkets.com/research/5a084e/optical_industry
64 - Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-July 30, 2009 - Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III study CRUISE showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean...
65 - Phase Forward Named to FORTUNE Small Business 100 List of Fastest-Growing Public Companies
WALTHAM, Mass.-(Business Wire)-July 30, 2009 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, is included in the FORTUNE Small Business 100 list for the second consecutive year, ranking 20th among America’s fastest-growing small...
66 - London & Pacific Healthcare CEO Announces Expanded Vision for Company
EL SEGUNDO, Calif.-(Business Wire)-July 30, 2009 - LONDON & PACIFIC HEALTHCARE, INC. (PINK SHEETS: LDPH) (FRANKFURT: EGU) (“London & Pacific” or the “Company”), the international healthcare advisory specialist, today announced that it intends to broaden its core healthcare advisory...
67 - ACADIA Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 5, 2009
SAN DIEGO-(Business Wire)-July 29, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited...
68 - Foresight Biotherapeutics Announces Initiation of Viral Conjunctivitis Clinical Trial
NEW YORK-(Business Wire)-July 28, 2009 - Foresight Biotherapeutics announced today that the first patient has been dosed in a viral conjunctivitis clinical trial. Foresight’s proprietary lead compound, FST-100, will be tested in a placebo-controlled, masked, and randomized multicenter clinical...
69 - ODS’ Next-Generation Health Activation Program
PORTLAND, Ore.-(Business Wire)-July 27, 2009 - ODS recently integrated the Patient Activation Measure (PAM)TM suite of tools into the company’s Healthcare Services care programs. The PAM suite of interactive tools dramatically enhances the company’s efforts to engage members in actively managing...
70 - Chinese Scientist Fanyi Zeng to Present at World Stem Cell Summit on iPS Cells Producing Viable Mice
WASHINGTON-(Business Wire)-July 23, 2009 - Fanyi Zeng, PhD., MD., of the Institute of Medical Genetics, Shanghai Jiao Tong University, a principal investigator in a new paper published in the scientific journal Nature this week, will present her work at the upcoming 2009 World Stem Cell Summit...
71 - Allergan Receives FDA Approval for ACUVAIL™ Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
IRVINE, Calif.-(Business Wire)-July 23, 2009 - Allergan, Inc. (NYSE: AGN) today announced that the United States Food and Drug Administration (FDA) has approved ACUVAIL™ (ketorolac tromethamine ophthalmic solution) 0.45%, an advanced, preservative-free formulation of ketorolac, a nonsteroidal...
72 - Alcon Reports Solid Financial Results for Second Quarter
Alcon, Inc. (NYSE:ACL) reported global sales of $1,677 million for the second quarter of 2009, a 3.3 percent increase excluding the impact of foreign exchange fluctuations, or a decrease of 3.4 percent compared to the second quarter of 2008 on a reported basis. Net earnings for the second quarter of...
73 - Alcon and AstraZeneca to Collaborate on Eye Drug Development
HUENENBERG, Switzerland-(Business Wire)-July 22, 2009 - Alcon (NYSE: ACL) announced today that it has entered into a five-year collaborative research agreement with AstraZeneca for the exclusive ophthalmic discovery and potential development rights to AstraZeneca’s compound library. The...
74 - Reportlinker Adds Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015
NEW YORK-(Business Wire)-July 22, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015...
75 - Foresight Biotherapeutics Announces Positive Results from an Open Label Pilot Study in Patients with Viral Conjunctivitis
NEW YORK-(Business Wire)-July 21, 2009 - Foresight Biotherapeutics, Inc. announced completion of a multi-center open-label pilot study of FST100 in the treatment of viral conjunctivitis. FST-100 is a novel formulation of dexamethasone that includes povidone iodine. The trial studied patients with...
76 - Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Retinopathy
TEL AVIV, Israel-(Business Wire)-July 21, 2009 - Compugen Ltd. (NASDAQ:CGEN) announced today that CGEN-25017, a novel peptide antagonist of the Angiopoietin/Tie-2 pathway, has shown positive therapeutic effects in an animal model of retinopathy, a very serious eye condition characterized by...
77 - Oraya Therapeutics Raises $42 Million in Series C Financing
NEWARK, Calif.-(Business Wire)-July 20, 2009 - Oraya Therapeutics, Inc., a medical technology company developing radiosurgical treatments for eye diseases, today announced that it has raised $42 million in Series C financing. Oraya will use the financing to expand its clinical trials with two...
78 - Xeloda®-Oxaliplatin Combination (XELOX) Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-July 20, 2009 - Genentech, Inc. announced today that an international Phase III study demonstrated that oral Xeloda® plus oxaliplatin (XELOX) is superior to a commonly used intravenous chemotherapy, 5-FU/LV (infused 5-fluorouracil plus leucovorin), in...
79 - Fera, an Emerging Pharmaceutical Company, Acquires a Portfolio of Ophthalmic Ointments
NEW YORK-(Business Wire)-July 16, 2009 - Fera Pharmaceuticals has acquired all rights, title and interest to seven prescription sterile anti-infective ophthalmic abbreviated new drug applications (ANDAs) marketed by Fougera, a division of Nycomed US Inc. The products include Bacitracin; Bacitracin...
80 - Ophthalmic Imaging Systems Announces that OIS EMR Version 4.1 Receives 08 CCHIT Certification
SACRAMENTO, Calif.-(Business Wire)-July 16, 2009 - The Certification Commission for Healthcare Information Technology (CCHIT®) announced that Ophthalmic Imaging System’s (“OIS” or “the Company”) (OTCBB:OISI) EMR Version 4.1 is a CCHIT Certified® 08 Ambulatory EHR, and meets the...
81 - Direct Capital Expands Medical Equipment Finance Division
PORTSMOUTH, N.H.-(Business Wire)-July 14, 2009 - Direct Capital, a leading nationwide provider of equipment leasing and financing, has taken several key steps to expand its Medical Equipment Finance Division. The company has announced that it will allocate nearly $68 million in lending capacity to...
82 - OptumHealth Donates More Than $2 Million in Eyeglass Frames to Prevent Blindness America
GOLDEN VALLEY, Minn.-(Business Wire)-July 9, 2009 - OptumHealth Inc. today announced that it is partnering with Prevent Blindness America, the nation’s oldest volunteer eye health and safety organization, to donate 50,000 eyeglass frames worth more than $2 million to residents in Ohio who...
83 - Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model
NEW YORK-(Business Wire)-July 9, 2009 - Foresight Biotherapeutics, Inc. today announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis. FST-100 demonstrated a...
84 - Research and Markets: Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015
DUBLIN-(Business Wire)-July 8, 2009 - Research and Markets Pipeline Technology and Market Forecasts to 2015" report is an essential source of information and analysis on the global IOLs market. The report identifies the key trends shaping and driving the dynamism in the global IOLs market. The...
85 - FGX International to Present at the Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure Conference
SMITHFIELD, R.I.-(Business Wire)-July 7, 2009 - FGX International (NASDAQ:FGXI), a leading designer and marketer of non-prescription reading glasses and sunglasses today announced that Alec Taylor, Chief Executive Officer and Anthony DiPaola, Chief Financial Officer will be presenting at the...
86 - Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis
EMERYVILLE, Calif. & HUENENBERG, Switzerland-(Business Wire)-July 5, 2009 - Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc. (NYSE-AMEX: NBY), announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay’s patented lead Aganocide...
87 - Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-July 2, 2009 - Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in...
88 - Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
HUENENBERG, Switzerland-(Business Wire)-July 2, 2009 - Alcon, Inc. (NYSE:ACL) announced today that it has discontinued development of anecortave acetate for the reduction of intraocular pressure (IOP) associated with glaucoma. The company recently reviewed interim efficacy and safety data from...
89 - Alcon Announces Second Quarter 2009 Financial Release and Conference Call Dates
HUENENBERG, Switzerland-(Business Wire)-July 1, 2009 - Alcon, Inc. (NYSE: ACL) will report on its second quarter financial results for the period ended June 30, 2009 after the market close on Wednesday, July 22, 2009. Management of the company will host a conference call to discuss these results...
90 - Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
WALTHAM, Mass.-(Business Wire)-June 30, 2009 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that GlaxoSmithKline (GSK) has signed multi-year, multi-million dollar contracts covering Licensing and Study Support...
91 - Eduardo C. Alfonso, M.D. Named Chairman of UM’s Bascom Palmer Eye Institute
MIAMI-(Business Wire)-June 30, 2009 - For only the fifth time in its 47-year history, the University of Miami’s Bascom Palmer Eye Institute has a new chairman. Eduardo C. Alfonso, M.D., known for his clinical expertise and research in eye diseases, corneal surgery and ocular microbiology, has been...
92 - AGTC and National Neurovision Research Institute Collaborate, Funding Research in two Genetic Retinal Diseases
GAINESVILLE, Fla.-(Business Wire)-June 29, 2009 - Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an agreement with the National Neurovision Research...
93 - Ophthalmic Imaging Systems Announces Private Equity Financing
SACRAMENTO, Calif.-(Business Wire)-June 29, 2009 - Ophthalmic Imaging Systems (“OIS” or “the Company”) (OTCBB:OISI), a leading digital imaging company, today announced it has signed a purchase agreement with U.M. AccelMed ("AccelMed"), Limited Partnership for a $6.0 million private placement...
94 - Inotek Pharmaceuticals’ Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure in Phase 1/2 Study
LEXINGTON, Mass.-(Business Wire)-June 25, 2009 - Inotek Pharmaceuticals today announced positive top-line results from a Phase 1/2 randomized, double-blind, placebo-controlled clinical trial of the Company’s lead candidate, INO-8875, in patients with glaucoma. Treatment with INO-8875 was well...
95 - New Online Vision Assessment Tool Helps Alert Parents to Potential Eye Problems in Children
PINE BROOK, N.J.-(Business Wire)-June 25, 2009 - According to the American Academy of Pediatrics (AAP), vision disorders are the fourth most common disability among children in the United States, yet many vision problems can take years to detect, making treatment more difficult as vital time passes...
96 - Medicity and Eclipsys Forge Strategic Partnership
ATLANTA & SALT LAKE CITY-(Business Wire)-June 24, 2009 - Medicity and Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®, announced today that the two companies are partnering to deliver a health information exchange, HealthXchange™, to Eclipsys clients. By leveraging Medicity’s...
97 - Compulink Debuts Low-Cost Solution for Ophthalmic and Optometric Electronic Health Records and Practice Management
WESTLAKE VILLAGE, Calif.-(Business Wire)-June 24, 2009 - Compulink Business Systems, the leader in electronic health records (EHR) and practice management software for ophthalmologists and optometrists, have announced the launch of two new products, Eyecare Advantage Essentials™ and E-Rx...
98 - Procedure Pioneered by Harry Marshak, MD, Reverses Ill Effects of Prior Eyelid Plastic Surgery
RANCHO MIRAGE, Calif.-(Business Wire)-June 23, 2009 - Since joining The Morrow Institute Specialty Plastic Surgery® group in Rancho Mirage, CA, ocular plastic surgeon Harry Marshak, MD, FACS has helped an average of 100 patients a year overcome issues caused by eyelid surgeries (blepharoplasty...
99 - Canon U.S.A. Introduces the CR-1 Mark II Digital Non-Mydriatic Retinal Camera for Eyecare Professionals
LAKE SUCCESS, N.Y.-(Business Wire)-June 23, 2009 - Adding to its line up of complete total digital imaging and workflow management solutions for eyecare professionals, Canon U.S.A., Inc., a leader in medical imaging, today introduced the CR-1 Mark II Digital Non-Mydriatic Retinal Camera. The CR-1...
100 - MDVIP Launches Preventive Medicine Pilot Program for Uninsured in Northern Virginia
BOCA RATON, Fla.-(Business Wire)-June 23, 2009 - On the heels of a successful partnership between MDVIP and Project Access in Palm Beach County, Florida, MDVIP will now roll out their second initiative to support the uninsured community in Northern Virginia. In collaboration with The INOVA Health...
101 - Acucela’s Novel Visual Cycle Modulator Demonstrates Promise as a Treatment for Dry Age-Related Macular Degeneration
BOTHELL, Wash.-(Business Wire)-June 23, 2009 - Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data on the company’s novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular...
102 - Puerto Rico’s HIMAHEALTH Now an Option in U.S. Healthcare
SAN JUAN, Puerto Rico-(Business Wire)-June 18, 2009 - HIMAHEALTH, a service provided by Puerto Rico hospital group Grupo HIMA San Pablo, will now offer Americans an affordable alternative to high healthcare costs just a short flight away in the U.S. Commonwealth of Puerto Rico. Offering cutting-edge...
103 - Dr. Paul Ashton, President/CEO of pSivida Corp and Internationally-Recognized Expert in Ophthalmic Drug Delivery Available for Comment on Allergan’s FDA Approval of Ozurdex Today
BOSTON-(Business Wire)-June 18, 2009 - pSivida Corp: WHO: Dr. Paul Ashton, President and CEO of pSivida Corp. (pronounced SIGH-VEE-da), the developers of the only other two FDA approved back of the eye drug delivery systems.... WHAT: is available for comment on the FDA approval today of...
104 - Allergan Receives FDA Approval for OZURDEX™ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
IRVINE, Calif.-(Business Wire)-June 18, 2009 - Allergan, Inc. (NYSE: AGN) today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX™ (dexamethasone intravitreal implant) 0.7 mg as the first drug therapy indicated for the treatment of macular edema following...
105 - Welch Allyn Implements Rural Telemedicine Project in Kingdom of Bhutan
SKANEATELES FALLS, N.Y.-(Business Wire)-June 18, 2009 - Welch Allyn, a leading global manufacturer of frontline products and solutions, and its distributor Samden Technologies recently assisted the Ministry of Health of the Kingdom of Bhutan in implementing the Rural Telemedicine Project, an...
106 - Akorn Acquires Capastat® Sulfate from Eli Lilly and Company
LAKE FOREST, Ill.-(Business Wire)-June 17, 2009 - Akorn, Inc. (NASDAQ: AKRX) today announced that it has entered into an agreement to acquire from Eli Lilly and Company (NYSE: LLY) all rights in the U.S. and Canada to manufacture, market and sell the lyophilized antibiotic Capastat® Sulfate...
107 - Resiliency in the Healthcare Sector Featured on CIT’s “5 Minute Capital” Podcast Series
NEW YORK-(Business Wire)-June 17, 2009 - CIT Group Inc. (NYSE: CIT), a leading provider of financing to small businesses and middle market companies, today released another installment of “5 Minute Capital” (www.5minutecapital.com), its award-winning series of five-minute podcasts featuring...
108 - Research and Markets: Ophthalmic Goods Manufacturing Industry in the U.S. and its International Trade, the Complete Q2 2009 Edition
DUBLIN-(Business Wire)-June 15, 2009 - Research and Markets . Revenue, Profitability & Foreign Trade Preview The industry's revenue for the year 2008 was approximately $6.0 billion USD, with an estimated gross profit of 47.4%. Import was valued at $3.3 billion USD from 69 countries. The industry...
109 - Two Newly-Published Scientific Papers Showed That the Steroid Used in Company’s Iluvien Device Acted as Both a VEGF Inhibitor and Neuroprotectant
BOSTON-(Business Wire)-June 15, 2009 - pSivida Corp. (NASDAQ:PSDV)(ASX:PVA), a leading drug delivery company, today announced that two newly-published peer reviewed scientific papers showed that Fluocinolone acetonide (FA) both inhibited VEGF production and protected retinal cells and function...
110 - Advanced Cell Technology and Collaborators at The Casey Eye Institute Present Promising Data Supporting Safety and Efficacy of Stem Cell Therapy to Combat Retinal Disease
WORCESTER, Mass.-(Business Wire)-June 12, 2009 - Advanced Cell Technology, Inc. (OTC:ACTC) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable...
111 - Jamie Freedman, M.D., Ph.D. Joins OPKO Health as Executive Vice President of R&D and Business Development
MIAMI-(Business Wire)-June 12, 2009 - OPKO Health, Inc. (NYSE Amex:OPK) today announced that Jamie Freedman, M.D., Ph.D., has joined OPKO as its Executive Vice President of R&D and Business Development. Dr. Freedman will play a critical role in developing the company’s research and development...
112 - Signature Eyewear Reports Increased Earnings in Second Quarter, 14th Consecutive Profitable Quarter
LOS ANGELES-(Business Wire)-June 10, 2009 - Signature Eyewear, Inc. (OTCBB:SEYE) reported net income of $216,000 ($.03 per share basic and fully diluted) on net sales of $6.1 million for the quarter ended April 30, 2009. This compares to net income of $212,000 ($.03 per share basic and fully...
113 - EuroMedtech™ Partnering Conference Introduces the Power of Productive Partnering to European Medtech Industry
CARLSBAD, Calif., ZURICH, Switzerland, and DUESSELDORF, Germany-(Business Wire)-June 10, 2009 - Leaders from the international medical technology industry gathered last week for the first annual EuroMedtech™ partnering conference. The conference was held on June 3–4 in Duesseldorf, Germany...
114 - Carl Zeiss Meditec Receives FDA Clearance for Cirrus HD-OCT Software Version 4.0
DUBLIN, Calif.-(Business Wire)-June 9, 2009 - A new suite of optical coherence tomography (OCT) software applications for the Cirrus™ HD-OCT has been cleared by the U.S. Food and Drug Administration (FDA) for commercial distribution. The Cirrus HD-OCT 4.0 with Retinal Nerve Fiber Layer and Macular...
115 - Carl Zeiss Meditec Receives FDA Clearance for Cirrus HD-OCT Software Version 4.0
DUBLIN, Calif.-(Business Wire)-June 9, 2009 - A new suite of optical coherence tomography (OCT) software applications for the Cirrus™ HD-OCT has been cleared by the U.S. Food and Drug Administration (FDA) for commercial distribution. The Cirrus HD-OCT 4.0 with Retinal Nerve Fiber Layer and Macular...
116 - Akorn Announces Management Changes
LAKE FOREST, Ill.-(Business Wire)-June 9, 2009 - Akorn, Inc. (NASDAQ:AKRX) today announced the appointment of Raj Rai as Interim Chief Executive Officer while the Board of Directors conducts a search to find a permanent replacement. Mr. Rai replaces Jeffery A. Whitnell, who is leaving the company to...
117 - InSite Vision Announces Clinical Development Plan for ISV-502
ALAMEDA, Calif.-(Business Wire)-June 8, 2009 - InSite Vision Incorporated (OTCBB: INSV) today reported that the company recently met with the U.S. Food and Drug Administration (FDA or “the Agency”) regarding the Phase 3 clinical program for ISV-502 (AzaSite Plus™). ISV-502 is a topical...
118 - Keep an Eye on Harmful UV Rays
MINNEAPOLIS-(Business Wire)-June 8, 2009 - Ultraviolet (UV) radiation is a concern for many Americans, but most people consider protecting their skin, not their eyes. Whether it’s a cloudy or sunny day, summer or winter, the Minnesota Optometric Association (MOA) reminds us to take specific...
119 - Vision-Ease Lens Working with The Skin Cancer Foundation to Promote Eye Protection Awareness
RAMSEY, Minn.-(Business Wire)-June 8, 2009 - With sun safety a growing concern for consumers and the sun season upon us, Vision-Ease Lens (VEL), manufacturer of Coppertone™ polarized lenses, and The Skin Cancer Foundation are working together to educate consumers about the importance of sun...
120 - Research and Markets: Government Initiatives Spearhead Growth in the European Ophthalmic Surgical Devices Market
DUBLIN-(Business Wire)-June 5, 2009 - Research and Markets, diabetic retinopathy, and cataract. Owing to the habits and lifestyles of the European population, the number of patients with eye disorders is likely to escalate, substantially expanding the market for ophthalmic surgical devices. Vision...
121 - Reportlinker Adds U.S. Eyewear Market: Prescription and Nonprescription Lenses, Sunglasses, Contact Lenses, and Frames
NEW YORK-(Business Wire)-June 4, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds U.S. Eyewear Market: Prescription and Nonprescription Lenses, Sunglasses, Contact Lenses, and Frames, 2nd Edition, The...
122 - ACADIA Pharmaceuticals to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009
SAN DIEGO-(Business Wire)-June 3, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the Eighth...
123 - InSite Vision Announces FDA Approval of New Ophthalmic Product Enabled by InSite’s DuraSite® Technology
ALAMEDA, Calif.-(Business Wire)-June 2, 2009 - InSite Vision Incorporated (OTCBB:INSV) today announced that Bausch & Lomb has received approval of Besivance™ (besifloxacin ophthalmic suspension) 0.6% for the treatment of bacterial conjunctivitis (“pink eye”) in patients one year and...
124 - KARL STORZ Announces Endorsement of the STERRAD® NX™ & STERRAD® 100NX™ Systems from ASP for Its Flexible Fiberscopes
EL SEGUNDO, Calif.-(Business Wire)-June 2, 2009 - KARL STORZ Endoscopy-America, Inc., a leader in diagnostic and operative minimally invasive endoscopic technology, announces that it is now endorsing the STERRAD NX and 100NX Systems as one of the approved sterilization methods for KARL STORZ...
125 - Compugen Appoints Dr. Anat Cohen-Dayag and Martin Gerstel as Co-CEOs
TEL AVIV, Israel-(Business Wire)-June 2, 2009 - Compugen (NASDAQ:CGEN) announced today the appointment of Anat Cohen-Dayag, Ph.D. and Martin Gerstel as co-CEOs of the company. Dr. Cohen-Dayag joined Compugen in 2002, and has held the positions of director of diagnostics, vice president for...
126 - International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells
OCEANSIDE, Calif.-(Business Wire)-May 27, 2009 - International Stem Cell Corporation (OTCBB:ISCO), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has received positive early results from animal trials designed to improve...
127 - Defense Solutions Holding, Inc. / DFSH Adds Eye Safety Systems Products to Its Offerings in Iraq
EXTON, Pa.-(Business Wire)-May 26, 2009 - Defense Solutions, Inc., an international project management and executive consulting firm, a wholly owned subsidiary of Defense Solutions Holding, Inc. (OTC Bulletin Board: DFSH), announces that the Company is an authorized distributor of Eye Safety...
128 - Lux Biosciences’ Luveniq™ (LX211) Highlighted at International Conference on Ocular Inflammation
JERSEY CITY, N.J.-(Business Wire)-May 26, 2009 - Lux Biosciences today announced that Luveniq (LX211, oral voclosporin) and its potential as a first-in-class treatment to reduce both active inflammation and disease recurrence in uveitis is being highlighted this week in a series of presentations...
129 - Alcon Breaks Ground in Singapore on First Asian Pharmaceutical Manufacturing Plant
HUENENBERG, Switzerland-(Business Wire)-May 26, 2009 - Alcon (NYSE: ACL), the world’s largest manufacturer of eye care products, marked the commencement of construction of its first pharmaceutical manufacturing plant in the Asian region today with a groundbreaking ceremony in Singapore’s Tuas...
130 - Uvex Stealth® Goggle Family Now Includes New Over-the-Glass Model
SMITHFIELD, R.I.-(Business Wire)-May 20, 2009 - Sperian Eye & Face Protection, the makers of Uvex® brand safety eyewear, is pleased to announce the newest addition to its Uvex Stealth goggle family: the Uvex Stealth OTG. Uvex Stealth OTG goggles protect against impact, dust and airborne...
131 - Welch Allyn Honors Sales and Marketing Excellence in U.S. and Canada
SKANEATELES FALLS, N.Y.-(Business Wire)-May 20, 2009 - Welch Allyn, a leading manufacturer of frontline medical products and solutions, recently honored four North American sales and marketing professionals with outstanding performance awards at its 2009 Sales Meeting in Clearwater, Florida...
132 - President of Israel Shimon Peres Tours Gamida Cell in Jerusalem
JERUSALEM-(Business Wire)-May 19, 2009 - Gamida Cell announced that the President of Israel, His Excellency Shimon Peres visited the company today for a briefing and a tour of the R&D facility. The purpose of the visit was for the president to learn more about the stem cell industry, which he...
133 - NanoViricides, Inc. Announces Additional Herpes Keratitis Study
WEST HAVEN, Conn.-(Business Wire)-May 19, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the Institutional Review Committee of a major research institute in New York has approved an investigator-initiated in vivo study which will evaluate certain topical...
134 - Acucela Founder to Present at BIO Business Forum
BOTHELL, Wash.-(Business Wire)-May 18, 2009 - Acucela founder and CEO Dr. Ryo Kubota will discuss the company’s work toward developing a treatment for age-related blindness at the BIO Business Forum May 18-21 at the Georgia World Congress Center in Atlanta, the company announced today. Data will...
135 - HumanaOne® Offers Individual Dental Insurance, Vision Plans Online
LOUISVILLE, Ky.-(Business Wire)-May 18, 2009 - Humana (NYSE:HUM) is now offering individual dental insurance and vision insurance products online under the umbrella of its individual health business, HumanaOne®. Web visitors can now check prices, compare plans and purchase HumanaOne individual...
136 - Can-Fite Announces Positive Results From Its Phase II Trial Treating Keratoconjunctivitis Sicca (Dry Eye Syndrome) With CF101
PETACH TIKVA, Israel-(Business Wire)-May 18, 2009 - Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 80-patient Phase II clinical study using CF101 to treat patients with moderate to severe...
137 - Ophthalmic Imaging Systems Announces First Quarter 2009 Results
SACRAMENTO, Calif.-(Business Wire)-May 15, 2009 - Ophthalmic Imaging Systems (OIS) (OTCBB: OISI), a leading digital imaging company, today reported its financial results for the first quarter ended March 31, 2009 and announced recent corporate developments. For the three months ended March 31, 2009...
138 - Research and Markets: Spain Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 Out Now
DUBLIN-(Business Wire)-April 30, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Spain Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and data...
139 - PASCAL® Photocoagulator Technology to Be Featured in 17 Presentations at Leading Ophthalmic Research Meeting
SANTA CLARA, Calif.-(Business Wire)-April 30, 2009 - OptiMedica Corp., a global ophthalmic company, has announced that its PASCAL Photocoagulator technology will be discussed as part of 17 presentations at The Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting, Fort...
140 - Research and Markets: Australia Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015
DUBLIN-(Business Wire)-April 29, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Australia Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and...
141 - StemCells, Inc. Collaborator to Present at Association for Research in Vision and Opthalmology Annual Meeting
PALO ALTO, Calif.-(Business Wire)-April 29, 2009 - StemCells, Inc. (NASDAQ:STEM) announced today that a paper regarding the efficacy of transplanting human neural stem cells in an animal model of retinal degeneration will be presented at the Association for Research in Vision and Opthalmology (ARVO...
142 - Foundation Fighting Blindness’ National Neurovision Research Institute Heralds Collaboration for Gene Therapy Advancements
OWINGS MILLS, Md.-(Business Wire)-April 29, 2009 - The National Neurovision Research Institute (NNRI), the Foundation Fighting Blindness’ clinical trial support organization, announced today that one of its key partners, biopharmaceutical company Oxford BioMedica, has established a collaboration...
143 - RTI Biologics Announces 2009 First Quarter Results
ALACHUA, Fla.-(Business Wire)-April 29, 2009 - RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2009 as follows: Quarterly Highlights: Achieved quarterly revenues of $38.6 million...
144 - Acucela Highlights Data to Be Presented at ARVO
BOTHELL, Wash.-(Business Wire)-April 28, 2009 - Acucela today announced it will present new data on ACU-4429, an investigational therapy for dry age-related macular degeneration (AMD), at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale...
145 - Visiogen Secures $40 Million in Equity Financing
IRVINE, Calif.-(Business Wire)-April 27, 2009 - Visiogen, Inc. of Irvine, California, announces that it has raised $40 million from new and current investors to support the global commercialization of the Synchrony® dual optic accommodating intraocular lens (IOL). Lead investor Novartis Venture...
146 - IOPtima: Successful Long-Term Results in the Use of its Novel Laser System for the Treatment of Glaucoma
RAMAT GAN, Israel-(Business Wire)-April 27, 2009 - IOPtima, a subsidiary of Bio-Light (TASE:BOLT), the developer of an innovative laser-based surgical device for reducing intra ocular pressure (IOP) for the treatment of glaucoma, successfully completed and analyzed the results of its first...
147 - PerkinElmer and Accelrys Announce Software Collaboration to Enable New Single Cell Imaging and Analysis Techniques
LILLE, France-(Business Wire)-April 27, 2009 - At the 15th Annual Society for Biomolecular Sciences Conference today, PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, announced a cellular imaging and analysis software relationship with Accelrys...
148 - Resolvyx to Present Data on Novel Resolvin Drug Candidates for Eye Disease at ARVO Annual Meeting
BEDFORD, Mass.-(Business Wire)-April 27, 2009 - Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that new preclinical data on its resolvin drug candidates will be presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting...
149 - FSDDS Announces Winners of 2009 Florida Sun Defense Essay Contest
JACKSONVILLE, Fla.-(Business Wire)-April 24, 2009 - The Florida Society of Dermatology and Dermatologic Surgery (FSDDS) recently held its Second Annual Sun Defense essay contest among elementary schools throughout the state of Florida. The purpose of the FSDDS Florida Sun Defense Essay Contest is to...
150 - Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies
CAMBRIDGE, England-(Business Wire)-April 24, 2009 - Pfizer Regenerative Medicine today announced that it has entered into a collaboration and license agreement with University College London focused on gaining better understanding into how to develop stem cell-based therapies for certain...
151 - Kaiser Permanente Celebrates Women’s Eye Health Month
PANORAMA CITY, Calif.-(Business Wire)-April 23, 2009 - During Women’s Eye Health Month, Kaiser Permanente reminds women that regular eye exams are a necessary part of their healthcare routine. Eye health should be a particular concern for women, as two-thirds of blindness and visual impairment...
152 - Sucampo Acquires Rights to Rescula for U.S. and Canada
BETHESDA, Md. & TOKYO-(Business Wire)-April 23, 2009 - Sucampo Pharmaceuticals, Inc., (NASDAQ:SCMP) and R-Tech Ueno, Ltd. (RTU) (Osaka Exchange Hercules code: 4573), today announced that Sucampo Pharma Americas, Inc. (SPA), a wholly owned subsidiary of Sucampo Pharmaceuticals Inc., licensed from...
153 - FGX International Announces First Quarter 2009 Earnings Call
SMITHFIELD, R.I.-(Business Wire)-April 23, 2009 - FGX International Holdings Limited (NASDAQ: FGXI) announced today that it expects to release first quarter 2009 financial results after the market closes on Wednesday, May 6, 2009. The Company will hold a conference call on Thursday, May 7, 2009 at...
154 - Charlotte Eye Ear Nose & Throat Associates Expands Treatment Options for Cataract Patients
CHARLOTTE, N.C.-(Business Wire)-April 23, 2009 - Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA), the region’s premier eye, ear, nose and throat care provider for adults and pediatric patients for more than 80 years, has added two new treatment options for cataract patients. CEENTA...
155 - pSivida Corp. Technology Featured in Multiple Abstracts at ARVO Meeting
WATERTOWN, Mass.-(Business Wire)-April 23, 2009 - pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PV3), a leading drug delivery company, today announced that seven abstracts describing its ophthalmic drug delivery products and technologies have been accepted by the Association for Research in Vision and...
156 - Alcon Reports Rise in First Quarter Earnings on Organic Sales Growth
HUENENBERG, Switzerland-(Business Wire)-April 22, 2009 - Alcon, Inc. (NYSE:ACL) reported global sales of $1,493.3 million for the first quarter of 2009, a 4.8 percent increase excluding the impact of foreign exchange fluctuations, or a decrease of 2.8 percent compared to the first quarter of 2008 on...
157 - Stanford Hospital & Clinics: Saying the Right Thing
STANFORD, Calif.-(Business Wire)-April 22, 2009 - “Can you hear me okay?” From her seat at the back of the hospital classroom, interpreter Amanda Pease whispered, in Spanish, into a tiny handheld microphone. At a conference table a dozen yards away, a young Hispanic man turned in her direction...
158 - ClearView Eye and Laser Medical Center Now Offers the Latest in Lash Enhancement - Latisse™
SAN DIEGO-(Business Wire)-April 22, 2009 - For thousands of years women have been using makeup to enhance the look of their eyes and lashes. But what if there was a way to encourage your lashes to grow longer and thicker, without makeup? Now there is and this innovative new lash enhancer...
159 - Avalon Healthcare Signs Contract with Lee Memorial Health System
TAMPA, Fla.-(Business Wire)-April 22, 2009 - Avalon Healthcare, Florida’s fast growing statewide individual and group health insurance plan, signed a provider agreement with Lee Memorial Health System (LMHS), which includes Lee Memorial Hospital, HealthPark Medical Center, Gulf Coast Hospital...
160 - Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-April 22, 2009 - Genentech, Inc. announced today that a Phase III study of Avastin® (bevacizumab) plus chemotherapy following surgery in patients with early-stage (adjuvant) colon cancer (NSABP C-08) did not meet its primary endpoint of reducing the...
161 - iScience Interventional, Inc. Closes $20.5 million Series F Financing
MENLO PARK, Calif.-(Business Wire)-April 21, 2009 - iScience Interventional, Inc., the developer of a novel microcatheter technology used in the treatment of a wide range of sight threatening diseases, including glaucoma and Age-related Macular Degeneration (AMD), today announced the closing of a...
162 - L Capital Invests $2 Million in iScience Interventional
NEW YORK-(Business Wire)-April 21, 2009 - L Capital Partners, L.P., a venture capital firm in New York City, is investing $2 million in a $20 million Series F round of financing for iScience Interventional. The round is being led by Affinity Venture Group; other investors include Johnson &...
163 - Deadline Set for Cubs Fans to Be in Upcoming Documentary Film
CHICAGO-(Business Wire)-March 11, 2009 - Do you really want to be in the movies? For the first time a documentary film production is seeking active viewer participation to support two charities. It’s not a starring role, but Chicago Cubs fans and admirers of the city of Chicago from around the...
164 - Advanced Cell Technology Secures $5 Million Credit Facility to Develop RPE Program for the Treatment of Diseases of the Eye
WORCESTER, Mass.-(Business Wire)-March 11, 2009 - Advanced Cell Technology, Inc. (“ACT” or the “Company”) (PINKSHEETS: ACTC) announced today that it has entered into a definitive agreement with a life sciences fund (the “Investor”), which has offices in New York and California, under...
165 - pSivida to Webcast Presentation at Cowen and Company Health Care Conference
BOSTON-(Business Wire)-March 11, 2009 - pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced it will webcast a live presentation at the Cowen & Company Annual Health Care Conference in Boston, March 16. Dr. Paul Ashton, president and chief executive...
166 - Surgical Procedures Performed in the United States are Increasing, Most Taking Place at Outpatient or Freestanding Healthcare Facilities, According to a New Report from Medtech Insight, Windhover Information
IRVINE, Calif.-(Business Wire)-March 10, 2009 - The number of surgical procedures performed in the U.S. is on the rise due to the increasing aging population and active baby boomer generation, while at the same time the percentage of these procedures performed on an inpatient basis is declining with...
167 - Alcon Signs Contract with LCA-Vision for 75 ALLEGRETTO WAVE® Excimer Lasers
HUENENBERG, Switzerland-(Business Wire)-March 10, 2009 - Alcon, Inc. (NYSE: ACL) announced today that its affiliate Alcon Laboratories, Inc. has signed a five year contract with LCA-Vision, Inc. (NASDAQ: LCAV). Under the contract, LCA will place ALLEGRETTO WAVE® Eye-Q 400Hz excimer lasers in all of...
168 - No Time for Complacency, Tough Stem Cell Policy Fights Ahead Says Genetics Policy Institute
WASHINGTON-(Business Wire)-March 9, 2009 - Follows is a statement by Bernard Siegel, Executive Director, Genetics Policy Institute (GPI), on President Obama’s decision to lift restrictions on federal funding for human embryonic stem cell research: “President Obama’s action today marks a...
169 - U.S. Preventive Medicine Praises President Obama’s Appeal for Modernizing Health Care System by Investing in Prevention
DALLAS-(Business Wire)-March 5, 2009 - U.S. Preventive Medicine®, the leader in disease prevention services, today applauded U.S. President Barack Obama’s call for modernizing the health care system by investing in prevention initiatives aimed at controlling costs and improving the health of...
170 - Open Your Eyes to Healthy Eating Habits
MINNEAPOLIS-(Business Wire)-March 5, 2009 - To build awareness of March’s Save Your Vision Month, Dr. Linda Chous, Glasses Menagerie, Minneapolis, and president of the Minnesota Optometric Association (MOA), reminds Minnesotans that caring for eyes includes paying attention to nutrition...
171 - MEDNAX to Present at Raymond James 30th Annual Institutional Investors Conference
FORT LAUDERDALE, Fla.-(Business Wire)-March 4, 2009 - MEDNAX, Inc., (NYSE:MD) today announced that it is scheduled to make a presentation on Monday, March 9, 2009, at 11:35 a.m. Eastern Time, to investors attending the Raymond James 30th Annual Institutional Investors Conference in Orlando, FL...
172 - InSite Vision Receives Notice of Delisting From NYSE Alternext US and Will Appeal Decision
ALAMEDA, Calif.-(Business Wire)-March 4, 2009 - InSite Vision Incorporated (NYSE Alternext US:ISV) today reported that NYSE Alternext US LLC (formerly known as the American Stock Exchange), or the Exchange, has notified InSite that it has not accepted the plan that the company filed in January...
173 - InSite Vision Reports Fourth Quarter and Full Year 2008 Financial Results and Outlines 2009 Priorities
ALAMEDA, Calif.-(Business Wire)-March 4, 2009 - InSite Vision Incorporated (AMEX:ISV) today reported financial results for the full year and fourth quarter ended December 31, 2008. For the year ended December 31, 2008, the company reported total revenue of $13.7 million compared to $23.8 million for...
174 - Research and Markets: Ocular Drug Delivery Companies Eye Greater Growth with Advances in Formulation Technology
DUBLIN, Ireland-(Business Wire)-March 4, 2009 - Research and Markets, 2008 For more information visit http://www.researchandmarkets.com/research/7fa39e/u_s_ocular_drug_d
175 - pSivida Corp: Enrollment complete in BrachySil™ Dose Ranging Study
WATERTOWN, Mass.-(Business Wire)-March 4, 2009 - pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a leading drug delivery company today announced the completion of enrollment of the BrachySil™ (P32 BioSilicon™) dose ranging clinical trial. Dr Paul Ashton, President and CEO of pSivida Corp. said...
176 - Examine the Ophthalmic Pharmaceuticals Market
NEW YORK-(Business Wire)-March 3, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023...
177 - New AcrySof® IQ Toric IOL Approved for U.S. Patients with Cataracts and Astigmatism
HUENENBERG, Switzerland-(Business Wire)-March 2, 2009 - Alcon, Inc. (NYSE: ACL), the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof® IQ Toric intraocular lens (IOL). The new lens offers an enhanced...
178 - Health Management Associates, Inc. to Present at the Barclays Capital 2009 Global Healthcare Conference
NAPLES, Fla.-(Business Wire)-March 2, 2009 - Health Management Associates, Inc. (NYSE:HMA) announced today that its management will give a presentation at the Barclays Capital 2009 Global Healthcare Conference to be held March 10-11, 2009, at the Loews Miami Beach Hotel in Miami Beach, Florida...
179 - Akorn Appoints Raj Rai as Strategic Consultant
LAKE FOREST, Ill.-(Business Wire)-March 2, 2009 - Akorn, Inc. (NASDAQ: AKRX) today announced the appointment of Raj Rai as Strategic Consultant to the Special Committee of the Board of Directors. As the company has previously announced, the Special Committee was established following the departure...
180 - Pluristem Therapeutics Receives FDA Clearance to Begin “First-In-Human” Placenta-Derived Stem Cell Clinical Trial
NEW YORK-(Business Wire)-March 2, 2009 - Pluristem Therapeutics Inc. (NasdaqCM:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that the US Food & Drug...
181 - Regeneron Reports Full Year and Fourth Quarter 2008 Financial and Operating Results
TARRYTOWN, N.Y.-(Business Wire)-February 26, 2009 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial and operating results for the full year and fourth quarter 2008. The Company reported a net loss of $82.7 million, or $1.05 per share (basic and diluted), for the year ended...
182 - Akorn Amplifies Form 8-K Disclosure
LAKE FOREST, Ill.-(Business Wire)-February 25, 2009 - Akorn, Inc. (NASDAQ: AKRX) today amplified its Form 8-K Regulation FD Disclosure filed with the Securities and Exchange Commission today. The Form 8-K reports that the Company is currently restricted from any further borrowings against its...
183 - FGX International Reports Strong Sales and Earnings Growth for the Fourth Quarter and Fiscal 2008
SMITHFIELD, R.I.-(Business Wire)-February 25, 2009 - FGX International (NASDAQ:FGXI), a leading designer and marketer of non-prescription reading glasses and sunglasses, today announced financial results for its fourth quarter and fiscal year ended January 3, 2009. Highlights for the quarter...
184 - Research and Markets: Competitor Analysis: Wet Age-Related Macular Degeneration (AMD)
DUBLIN, Ireland-(Business Wire)-February 25, 2009 - Research and Markets in the central part of the eye. While no treatment is available for this condition, vitamin supplements appear to slow the progression of dry macular degeneration and, in some patients, improve visual acuity. Neovascular or...
185 - RTI Biologics Launches Two Biologic Implants at Orthopaedic Surgeon Annual Meeting
ALACHUA, Fla.-(Business Wire)-February 25, 2009 - RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries at the American Academy of...
186 - Advanced Medical Optics, Inc. Announces Expiration and Results of Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017
SANTA ANA, Calif.-(Business Wire)-February 25, 2009 - Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) announced today the expiration of the tender offer and consent solicitation (the “Offer”) for its outstanding 7½% Senior Subordinated Notes due 2017 (the “Notes”) (CUSIP No. 00763MAN8...
187 - Metropolitan Health Networks Reports 2008 Results of Operations
WEST PALM BEACH, Fla.-(Business Wire)-February 25, 2009 - Metropolitan Health Networks, Inc. (NYSE Alternext US:MDF), a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2008. Highlights include the...
188 - The LCA-Vision Full Value Committee Files Detailed Presentations
CINCINNATI-(Business Wire)-February 25, 2009 - The LCA-Vision Full Value Committee announced today that it has filed presentations with the Securities and Exchange Commission in connection with the Full Value Committee’s solicitation of consents to replace the existing Board of Directors of...
189 - FGX International Names Alfred J. Verrecchia to Board of Directors
SMITHFIELD, R.I.-(Business Wire)-February 24, 2009 - FGX International (NASDAQ:FGXI), a leading designer and marketer of non-prescription reading glasses and sunglasses, today announced that Alfred J. Verrecchia has been appointed to its Board of Directors for a term ending at the 2009 Annual...
190 - FairWarning® Hosting No-Charge Educational Webinar on ARRA 2009 Privacy, Security and HIPAA Provisions
ST. PETERSBURG, Fla.-(Business Wire)-February 24, 2009 - FairWarning, Inc., the world’s leading supplier of cross-platform healthcare privacy auditing solutions for Electronic Health Records (EHRs), today announced that the company has organized an educational HIPAA webinar, scheduled for March...
191 - Genentech Announces March 2, 2009 Webcast of Investment Community Meeting
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-February 23, 2009 - Genentech, Inc. (NYSE:DNA) invites investors, the media and the general public to listen to a live webcast of its investment community meeting in New York. The webcast will begin on Monday, March 2, 2009, at 9:00 a.m. Eastern Time...
192 - Genentech Special Committee Rejects Roche’s $86.50 Offer as Inadequate
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-February 23, 2009 - Genentech, Inc. (NYSE:DNA) today announced that a Special Committee of its Board of Directors unanimously recommended that shareholders reject the unilateral tender offer from Roche to acquire all of the outstanding shares of...
193 - Cooper Announces Release Date for First Quarter 2009
PLEASANTON, Calif.-(Business Wire)-February 23, 2009 - The Cooper Companies, Inc. (NYSE:COO) today announced that it will release first quarter 2009 financial results on Thursday, March 5, 2009 at 4:00 PM ET. Following the release, the company will host a conference call and live webcast with...
194 - Research and Markets: The Global Strategic Business Report on Optical Coatings
DUBLIN, Ireland-(Business Wire)-February 23, 2009 - Research and Markets . The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 124 companies...
195 - Clinical Results with RegeneRx’s Ophthalmic Drug Candidate Subject of Oral Presentation at 2009 ARVO Meeting
BETHESDA, Md.-(Business Wire)-February 23, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Alternext US:RGN) announced today that an oral presentation entitled “The Use of Thymosin Beta 4 to Promote Healing of Neurotrophic Corneal Ulcers” will be presented at the 2009 Association for Research...
196 - Lasik to the Stars!
SUNRISE, Fla.-(Business Wire)-February 23, 2009 - Some of today’s leading celebrities in the world of entertainment and sports are now able to “see and be seen” in a completely different light thanks to the prolific skill and surgical prowess of the nation’s top LASIK specialist. Cory M...
197 - Research and Markets: SWOT Review of the Key Ophthalmic Device Companies: An Essential Source of High Quality Information
DUBLIN, Ireland-(Business Wire)-February 23, 2009 - Research and Markets , procedure numbers, pricing trends and competitive landscape Viewpoints provide in depth analysis of market drivers, restraints and trends impacting the future of the sectors and sub-sectors Viewpoints are analytical alerts...
198 - Uvex® Launches New Interactive Safety Eyewear Website
SMITHFIELD, R.I.-(Business Wire)-February 20, 2009 - Sperian Protection, the world leader in Personal Protective Equipment (PPE), has launched a redesigned website for Uvex®, its flagship brand of premium quality, state-of-the-art, feature-rich safety eyewear, goggles and face shields. The new...
199 - Ophthalmic Imaging Systems Comments on Potential Impact of U.S. Government’s Stimulus Package on Electronic Health Records Market
SACRAMENTO, Calif.-(Business Wire)-February 20, 2009 - Ophthalmic Imaging Systems (OIS) (OTCBB: OISI) and Abraxas Medical Solutions, Inc., a wholly-owned subsidiary of OIS and a provider of state of the art Electronic Health Record (EHR) solution, commented on a portion of the American Recovery...
200 - Acucela Founder to Speak at Ophthalmology Conference
BOTHELL, Wash.-(Business Wire)-February 19, 2009 - Acucela founder and CEO Dr. Ryo Kubota will be a featured speaker at a symposium highlighting revolutionary pharmacotherapies in development and clinical practice to treat debilitating eye diseases, the company announced today. Dr. Kubota has been...
Search Our News Using Google Search
Can't find what you want? Try using Google:
